Abbott closes OptiMedica acquisition

Abbott has completed its purchase of Silicon Valley-based ophthalmic device maker OptiMedica Corporation for $250 million in cash and additional milestone payments of up to $150 million.

Announced in July, the acquisition expands Abbott's vision care business into the femtosecond laser-assisted cataract surgery market. OptiMedica’s Catalys femtosecond laser system has both the CE Mark in Europe and clearance from the FDA. It includes a femtosecond laser, integrated 3-D optical coherence tomography imaging, and pattern scanning technology.